Deregulation Phase II rolled out in January 2026, expands compliance reduction push: Economic Survey
State capacity is built not only through new institutions or additional controls, but through disciplined removal of frictions that impede productive activity. Phase II of deregulation launched in Jan ...
Boehringer Ingelheim announced results from a 12-week phase II clinical trial evaluating apecotrep (BI 764198), an oral, potential first-in-class, non-immunosuppressive TRPC6 inhibitor for people with ...
Apecotrep (BI 764198) is a potential first-in-class, oral, selective TRPC6 inhibitor being investigated as a novel, targeted, non-immunosuppressive therapy in people with primary focal segmental ...
Apecotrep (BI 764198) is a potential first-in-class, oral, selective TRPC6 inhibitor being investigated as a novel, targeted, non-immunosuppressive therapy in people with primary focal segmental ...
Nanotechnology has become a focal point in contemporary research, finding applications across diverse sectors, such as bioengineering, pharmaceuticals, agriculture, metallurgy, and materials science ...
Lords of the Fallen II publisher CI Games has shown gameplay footage of its Soulslike sequel during The Game Awards 2025, featuring new character Omeuras and enemy limbs flying everywhere. Ahead of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results